Johnson Fistel, PLLP is investigating potential claims for investors of Embecta Corp following the company's report of a 14.4% revenue decline and a lowered full-year outlook. Embecta cut its revenue guidance and earnings per share estimates, citing U.S. market pressures and competitive losses, which led to a sharp drop in its stock price. The law firm is examining whether Embecta's executives complied with federal securities laws and encourages affected investors to contact them for possible recovery of losses.
In 2026, a new wave of immunotherapy treatments is advancing against historically resistant solid tumors such as prostate and pancreatic cancer. GT Biopharma initiated a Phase 1 trial for GTB-5550, a natural killer cell engager targeting seven solid ...
US stock futures gained following a mixed market close and President Trump's approval of Nvidia's H200 AI chip sales to Chinese firms, although China has halted deliveries. Economic data showed a 0.5% rise in April retail sales and a slight increase ...
Sumitomo Forestry has finalized its acquisition of Tri Pointe Homes for $47 per share, making Tri Pointe a wholly owned subsidiary and delisting it from the NYSE. This deal expands Sumitomo Forestry's U.S. homebuilding presence to 18 states, deliveri...
Verde Resources Inc. announced its invitation to the GenZero Climate Summit 2026 in Singapore, a key event focused on advancing net zero solutions. The company aims to expand its presence in Singapore and Southeast Asia, leveraging its newly establis...
Boeing shares rose following Treasury Secretary Scott Bessent's indication of significant aircraft orders from China during President Trump's meeting with Chinese President Xi Jinping. The U.S.-China tariff dispute had previously halted Boeing delive...
